$PTGX
Protagonist Therapeutics, Inc
XNAS•Health Care•Pharmaceutical Preparations
$139.91
▼-0.72%-$1.01
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateProtagonist Therapeutics, Inc
XNAS•Health Care•Pharmaceutical Preparations
Why is PTGX down today? It is at $139.91 (-0.72%), and our scanner flagged it 59 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PTGX spikes, and full due diligence on PTGX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $PTGX 59 times in the last 30 days. Create a free account to track $PTGX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
PTGX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 10 unusual-volume and momentum alerts on PTGX today, peaking at 82.5x its normal volume.
Likely catalystProtagonist Therapeutics, Inc: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing4Ownership documentOct 2, 2026 · 6 days agoWe could not reach SEC EDGAR, so the dilution check did not run. This is not a clean result - verify on EDGAR before trading.
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Ali Asif Officer | Sold (automatic/other) | -59K 0.09% of company | sold 50% | 59K | $8.3M at $141.77 | Sep 30, 26 |
Ali Asif Officer | Other | 59K 0.09% of company | added 99% | 118K | $714K at $12.17 | Sep 30, 26 |
Patel Dinesh V Ph D Officer | Sold (automatic/other) | -7K 0.01% of company | sold 1.4% | 523K | $1.0M at $144.10 | Sep 10, 26 |
Patel Dinesh V Ph D Officer | Other | 7K 0.01% of company | added 1.4% | 530K | $157K at $21.58 | Sep 10, 26 |
Patel Dinesh V Ph D Officer | Sold (automatic/other) | -64K 0.10% of company | sold 11% | 523K | $9.3M at $146.18 | Sep 9, 26 |
Patel Dinesh V Ph D Officer | Other | 64K 0.10% of company | added 12% | 587K | $1.4M at $21.58 | Sep 9, 26 |
Patel Dinesh V Ph D Officer | Sold (automatic/other) | -54K 0.08% of company | sold 9.4% | 523K | $7.9M at $145.87 | Sep 8, 26 |
Patel Dinesh V Ph D Officer | Other | 54K 0.08% of company | added 10% | 577K | $1.2M at $21.58 | Sep 8, 26 |
Patel Dinesh V Ph D Officer | Sold (automatic/other) | -510 | sold <0.1% | 523K | n/a | Sep 3, 26 |
Patel Dinesh V Ph D Officer | Sold (automatic/other) | -34K 0.05% of company | sold 6.1% | 523K | $5.1M at $148.52 | Aug 11, 26 |
Patel Dinesh V Ph D Officer | Other | 34K 0.05% of company | added 6.5% | 558K | $739K at $21.58 | Aug 11, 26 |
Patel Dinesh V Ph D Officer | Sold (automatic/other) | -66K 0.1% of company | sold 11% | 523K | $9.8M at $149.11 | Aug 10, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
PTGX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 10 unusual-volume and momentum alerts on PTGX today, peaking at 82.5x its normal volume.
PTGX last traded at $139.91, down 0.72% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Protagonist Therapeutics, Inc (PTGX) is next expected to report earnings on Thursday, November 5, 2026, about 28 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The PTGX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PTGX 59 times in the last 30 days.
PTGX (Protagonist Therapeutics, Inc) trades on XNAS, with a market cap of about $9.05B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PTGX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PTGX discussion
Sign in to ask a question or join the discussion.